Loading insider details...
Beta
Latest Form 4 (Jan 8, 2026): Sale of 23,766 RNAC shares, $162.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 8, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Sale | 23,766 | $162.1K |
| Jan 6, 2026 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 143,200 | n/a |
| Jan 8, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Sale | 8,563 | $143.2K |
| Jan 6, 2025 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 57,500 | n/a |
| Jan 4, 2024 | Cartesian Therapeutics, Inc. (RNAC) | Grant/Award | 4,654,100 | n/a |
| Nov 15, 2023 | Cartesian Therapeutics, Inc. (RNAC) | Disposition to Issuer | 55,000 | $113.3K |
| Sep 26, 2023 | SELECTA BIOSCIENCES INC (SELB) | Sale | 2,932 | $3.1K |
| Jan 6, 2023 | SELECTA BIOSCIENCES INC (SELB) | Sale | 27,549 | $31.2K |
| Jan 4, 2023 | SELECTA BIOSCIENCES INC (SELB) | Grant/Award | 282,800 | n/a |
| Dec 7, 2022 | SELECTA BIOSCIENCES INC (SELB) | Sale | 4,522 | $6.0K |